Compumedics Ltd Total Assets

Latest as of June 2025: AU$54.39 Million AUD ≈ $38.48 Million USD

Compumedics Ltd total assets. Based on the latest financial reports, Compumedics Ltd (CMP) holds total assets worth AU$54.39 Million AUD (≈ $38.48 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Compumedics Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Total Assets of Compumedics Ltd (2000–2025)

Total assets of Compumedics Ltd from 2000 to 2025. This chart illustrates how Compumedics Ltd's total assets have evolved over time, based on quarterly financial data. See current stock price of Compumedics Ltd for real-time trading data and today's change.

Compumedics Ltd - Asset Composition Analysis

Compumedics Ltd Total Assets Breakdown (June 2025)

Compumedics Ltd total assets breakdown as of June 2025. Compumedics Ltd's total assets of AU$54.39 Million consist of 64.8% current assets and 35.3% non-current assets.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$0.00 5.0%
Accounts Receivable AU$14.88 Million 27.4%
Inventory AU$14.66 Million 27.0%
Property, Plant & Equipment AU$1.78 Million 3.3%
Intangible Assets AU$16.59 Million 30.5%
Goodwill AU$0.00 0.0%

Asset Composition Trend (2000–2025)

This chart illustrates how Compumedics Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Compumedics Ltd to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Compumedics Ltd's current assets represent 64.8% of total assets in 2025, a decrease from 66.0% in 2000.
  • Cash Position: Cash and equivalents constituted 5.0% of total assets in 2025, down from 38.0% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 21.0% in 2000.
  • Asset Diversification: The largest asset category is intangible assets at 30.5% of total assets.

Compumedics Ltd Competitors by Total Assets

Key competitors of Compumedics Ltd based on total assets are shown below.

Company Country Total Assets
Cochlear Ltd
AU:COH
Australia AU$2.83 Billion
Vitrolife AB
ST:VITR
Sweden Skr11.30 Billion
Sinocare Inc
SHE:300298
China CN¥6.25 Billion
Shanghai Sanyou Medical Co Ltd
SHG:688085
China CN¥2.34 Billion
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
China CN¥7.51 Billion
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
China CN¥1.79 Billion
TAIDOC TECHNOLOGY CORP
TW:4736
Taiwan NT$13.07 Billion
SS Innovations International Inc. Common Stock
NASDAQ:SSII
USA $96.98 Million

Compumedics Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.10 1.23 2.32
Quick Ratio 0.64 0.61 1.61
Cash Ratio 0.00 0.00 0.00
Working Capital AU$3.10 Million AU$4.99 Million AU$16.45 Million

Compumedics Ltd - Advanced Valuation Insights

This section examines the relationship between Compumedics Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.22
Latest Market Cap to Assets Ratio 0.62
Asset Growth Rate (YoY) 34.8%
Total Assets AU$54.39 Million
Market Capitalization $33.92 Million USD

Valuation Analysis

Below Book Valuation: The market values Compumedics Ltd's assets below their book value (0.62x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Compumedics Ltd's assets grew by 34.8% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Compumedics Ltd (2000–2025)

The table below shows the annual total assets of Compumedics Ltd from 2000 to 2025.

Year Total Assets Change
2025-06-30 AU$54.39 Million
≈ $38.48 Million
+34.77%
2024-06-30 AU$40.36 Million
≈ $28.56 Million
-2.00%
2023-06-30 AU$41.18 Million
≈ $29.14 Million
-1.26%
2022-06-30 AU$41.71 Million
≈ $29.51 Million
+8.21%
2021-06-30 AU$38.55 Million
≈ $27.27 Million
+8.50%
2020-06-30 AU$35.53 Million
≈ $25.14 Million
-8.11%
2019-06-30 AU$38.66 Million
≈ $27.36 Million
+11.57%
2018-06-30 AU$34.65 Million
≈ $24.52 Million
+18.56%
2017-06-30 AU$29.23 Million
≈ $20.68 Million
+11.89%
2016-06-30 AU$26.12 Million
≈ $18.48 Million
+20.52%
2015-06-30 AU$21.68 Million
≈ $15.34 Million
+11.03%
2014-06-30 AU$19.52 Million
≈ $13.81 Million
+2.28%
2013-06-30 AU$19.09 Million
≈ $13.51 Million
-3.96%
2012-06-30 AU$19.88 Million
≈ $14.06 Million
-13.98%
2011-06-30 AU$23.10 Million
≈ $16.35 Million
+5.93%
2010-06-30 AU$21.81 Million
≈ $15.43 Million
+1.65%
2009-06-30 AU$21.46 Million
≈ $15.18 Million
+6.53%
2008-06-30 AU$20.14 Million
≈ $14.25 Million
+4.63%
2007-06-30 AU$19.25 Million
≈ $13.62 Million
-13.19%
2006-06-30 AU$22.18 Million
≈ $15.69 Million
-9.67%
2005-06-30 AU$24.55 Million
≈ $17.37 Million
+0.16%
2004-06-30 AU$24.51 Million
≈ $17.34 Million
+3.14%
2003-06-30 AU$23.76 Million
≈ $16.81 Million
-45.53%
2002-06-30 AU$43.62 Million
≈ $30.87 Million
+11.29%
2001-06-30 AU$39.20 Million
≈ $27.73 Million
+13.75%
2000-06-30 AU$34.46 Million
≈ $24.38 Million
--

About Compumedics Ltd

AU:CMP Australia Medical Devices
Market Cap
$33.92 Million
AU$47.94 Million AUD
Market Cap Rank
#23097 Global
#844 in Australia
Share Price
AU$0.24
Change (1 day)
+4.35%
52-Week Range
AU$0.22 - AU$0.45
All Time High
AU$0.90
About

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST… Read more